Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

47.64 +4.30 (+9.92%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 36,856,625
Open 46.37
Bid (Size) 49.60 (1,000)
Ask (Size) 50.00 (200)
Prev. Close 43.34
Today's Range 45.84 - 47.74
52wk Range 43.08 - 93.80
Shares Outstanding N/A
Dividend Yield 2.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider. 
Via The Motley Fool
News headline image
Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut ↗
Via MarketBeat

Performance

YTD
-9.1%
-9.1%
1 Month
-16.9%
-16.9%
3 Month
+3.7%
+3.7%
6 Month
-4.5%
-4.5%
1 Year
-44.9%
-44.9%

More News

Read More
News headline image
HIMS Stock Slumps After-Hours On Regulatory Scrutiny On Heels Of Compounded Wegovy Pill Launch ↗
Via Stocktwits
News headline image
Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition
Via MarketMinute
Topics Earnings Economy
HIMS Stock Plunges 10% After Hours: FDA Chief Warns Of ‘Swift Action’ On Copycat Drugs After Novo Semaglutide Knockoff Launch ↗
Via Stocktwits
Novo Nordisk Threatens Legal Action Against Hims & Hers Over Compounded Wegovy Pill ↗
Via Stocktwits
News headline image
Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore ↗
Via The Motley Fool
News headline image
The $49 Disruptor: Hims & Hers Ignites a Brutal Price War in the Weight-Loss Drug Market
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
News headline image
Why Shares of Novo Nordisk Stock Collapsed This Week ↗
Via The Motley Fool
News headline image
The Trillion-Dollar Divergence: Eli Lilly Hits Milestone While Novo Nordisk Faces 'Supply Chain Reset'
Via MarketMinute
Topics Economy
News headline image
Why Did AMD, Uber, and Novo Nordisk Stock Crash This Week? ↗
Via The Motley Fool
News headline image
The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance
Via Finterra
Topics Economy Government Intellectual Property
News headline image
Eli Lilly Stock Has Over 20% Upside, Analysts Say: Retail Seeks Pharma 'Safe Haven' As FDA Targets GLP-1 Copycats ↗
Via Stocktwits
Topics Fraud Law Enforcement
News headline image
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. ↗
Via The Motley Fool
News headline image
Trade War 2.0: 25% Tariffs on Chips, Cars, and Medicine Reshape the Global Supply Chain
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts
Via MarketMinute
Topics Earnings Economy
News headline image
Hims & Hers Takes On Novo Nordisk: What We Know Right Now ↗
Via The Motley Fool
News headline image
OAK Family Advisors Sells $4 Million of NICE Stock ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Eli Lilly Just Delivered Fantastic News to Shareholders ↗
Via The Motley Fool
Topics Government
News headline image
Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports ↗
Via Stocktwits
Topics Economy Government World Trade
News headline image
Healthcare Titans Propel Dow to Record Highs as GLP-1 Sales Spark Major Market Rotation
Via MarketMinute
Topics Artificial Intelligence Earnings Intellectual Property
News headline image
Why Eli Lilly Stock Just Dropped ↗
Via The Motley Fool
News headline image
HIMS New $49 Pill Lifts Stock 10%, But Why Are NVO, LLY Stocks Falling? ↗
Via Stocktwits
Topics Intellectual Property
News headline image
The $1 Trillion Apothecary: A Deep-Dive Research Report on Eli Lilly (LLY)
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
The Metabolic Split: Why Eli Lilly Soars as Novo Stumbles ↗
Via MarketBeat

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 47.64
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 02/06/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.